Your session is about to expire
← Back to Search
NAD+ Boosting Product
The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care
Phase 2
Waitlist Available
Led By David Crowley, MD
Research Sponsored by Limitless Research Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a supplement called 'Limitless' combined with a low-carb diet in adults aged 45-65 with hypertension who are not on statin therapy. The supplement aims to improve blood flow and reduce inflammation, while the diet helps stabilize blood sugar levels.
Eligible Conditions
- High Blood Pressure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes to blood nitrate from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
Peroxynitrite
Changes to blood pressure from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
+3 moreSecondary study objectives
Changes to C-reactive protein from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
Changes to C-reactive protein from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30
Changes to L-arginine from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30
+35 moreOther study objectives
Change in Alanine Aminotransferase After 30 day supplementation with Limitless in addition to a low carbohydrate diet
Change in Amount of Basophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet
Change in Amount of Eosinophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet
+26 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: LimitlessExperimental Treatment1 Intervention
Participants will be instructed to take Limitless capsules for 30 days starting with the first dose to be administered in clinic on Visit 2 (Day 1, Baseline). The last dose will occur in clinic on Visit 3 (Day 30). Participants will be instructed to take two capsules two hours with water after breakfast, and two capsules two hours after dinner. Do not take food after evening dose before bed. (i.e. no snacking or desserts.). If a dose is missed participants are instructed to skip that dose. Participants will be advised not to exceed four capsules daily.
Find a Location
Who is running the clinical trial?
KGK Science Inc.Industry Sponsor
79 Previous Clinical Trials
6,168 Total Patients Enrolled
Limitless Research Inc.Lead Sponsor
David Crowley, MDPrincipal InvestigatorKGK Science Inc.
37 Previous Clinical Trials
2,801 Total Patients Enrolled